Saturday, October 31, 2026

MedMen Q4 Earnings: Burns $316M cash in Fiscal 2019

After the bell, Medmen Enterprises (CSE: MMEN) released their 4th quarter earnings. The headline for the quarter in our opinion is the combined annual cash burn of $316.87M (combined operating and investing cash flows).

When I breakdown quarterly numbers, I like to look at some of the key data on a quarter over quarter basis:

 Q4Q3% change
Revenue42.036.614.7%
Gross Margin16.015.53.1%
Gross Marin %38.1%42.4% 
System Wide Revenue42.036.614.8%
G&A Expense51.361.3-16.2%
Sales and Marketing Expense7.46.710.6%
Net Loss-82.9-63.131.5%
Operating Cash Flow-51.9-59.2-12.4%
Investing Cash Flow-41.127.5 
Adjusted EBITDA-39.4-42.6-7.4%

From The Conference Call

  • There remains $125M of cash on the facility from Gotham Green, which they are planning to restructure to current market conditions.
  • Targeting 30 stores in California by the end of next fiscal year.
  • The companies long run goal is 60% retail gross margins.
  • Majority of cash burn moving forward is on the operating side, ie. ramping stores, not on building facilities.
  • Main focus is on California, Florida and New York.
  • Company is targeting a full 30% reduction in SG&A.

Breakdown of Expenses

From the notes, we can see some of the significant line items on SG&A. Where it is interesting to note the nearly $8M spent on travel and entertainment.

Also of note, the company’s executives received around $21M in share-based compensation, which is likely comprised of way out of the money options that will never be exercised.

On the cash concerns. The company has nearly $90M in convertibles (which are way out of the money), plus another $70M in accounts and notes payable all due in less than one year.

Overall Thoughts On The Quarter

Medmen remains one of the most interesting companies in the cannabis public markets. The company has invested more money into building out brands than anyone else in the space. They are the market leader, in a highly fragmented state that often sets the tone for brands across the US.

PTX Metals Inc. — sponsored Sponsored · PTX Metals Inc.

Overall, the company only grew topline revenue by 15% quarter over quarter and continues to burn cash at an alarming rate. Investors will want to keep a keen eye on the companies ability to raise cash over the next few quarters. Medmen tells us they had gross margins of 50% vs. 53% last quarter for retail, which we cannot assess because this a non-IFRS number and the gross margins reflected on the income statement is actually sub 40%. At the time of the conference call, the company still had yet to publish the full statements on sedar.


Information for this briefing was found via Sedar and MedMen. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Copper Mine Costs 1/6 to Restart | SSR Mining X Roxmore

Why Cambria Hit Pause on Its Massive Copper-Gold Spinout

Can Gold Rescue Washington From Its Debt Trap? | Andy Schectman – Miles Franklin

Recommended

Mercado Minerals Lengthens El Triunfo Vein by 190 Metres, Readies 1,500-Metre Zamora Drill Program

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Related News

Canopy’s Quarter in Charts

Whenever there’s a negative margin, those of us in the financial content biz like to...

Sunday, November 17, 2019, 08:58:03 AM

Tilray: Analysts Leave Targets Unchanged After MedMen Investment

On August 17, Tilray (NASDAQ: TLRY) made the announcement that they formed a new limited...

Thursday, August 19, 2021, 01:03:00 PM

Analyzing Medmen CEO Adam Bierman’s Response To Market Rumours

For those focused on the cannabis sector, you’re likely aware of a drama that has...

Thursday, January 23, 2020, 10:48:21 AM

MedMen Sees CEO, Chairman Exit, Appoints Restructuring Officer

MedMen Enterprises (CSE: MMEN) appears to be near the end of the line, with the...

Wednesday, January 24, 2024, 05:51:13 PM

Medmen: Canaccord Drops Price Target To $0.35 After Q1 Results

On November 9th, Medmen Enterprises (CSE: MMEN) reported their fiscal first-quarter financial results. The company...

Sunday, November 14, 2021, 10:03:00 AM